Introduction
Melanoma risk is positively associated with intermittent sun exposure and may be modestly inversely associated with a high continuous pattern of sun exposure (1) . Solar elastosis, which is generally considered to be a biomarker for cumulative sun exposure, is frequently found adjacent to melanoma in histologic sections and is available for assessment by pathologists. The distinguishing feature of histologic solar elastosis is accumulation of abnormal elastotic fibers in the upper and middle dermis, which may be related to activation of the human elastin promoter by ultraviolet (UV) radiation (2) or to an influx of neutrophils that diffuse to the dermis in response to cytokine production after UVB exposure and degrade elastin (3) . In albino hairless mice, the UV erythema spectrum was the most predictive for elastosis quantified by computerized image analysis (4) . The importance of better understanding the relationship of age, sun exposure behavior and patient phenotype with solar elastosis among melanoma and other skin cancer patients is underscored by the use of solar elastosis as a biomarker in investigations of melanoma etiology (5) (6) (7) (8) and outcome (9) (10) (11) (12) (13) .
Recent epidemiological studies have explored environmental and personal determinants of skin damage, including whether there are separate effects of chronological aging and cumulative sun damage. These studies included people with BCC or SCC (14) , melanoma (5) or were drawn from the general population (15) and examined either histologic solar elastosis (5, 14) or silicone cast score (5) . While severe solar elastosis was found to occur more frequently on more heavily sun-exposed sites, no particular phenotypic determinant was identified in association with sun damage and only one study sought to identify the most predictive measure of sun exposure (14) . Each participant provided informed consent to obtain diagnostic slides of their melanoma for a standardized pathology review. Expert dermatopathologists scored adjacent solar elastosis on the same slides as the melanomas using a grading system (absent, mild/moderate, or severe)
that correlated approximately to the chronic sun damage (CSD) levels proposed by Landi et al. (8) . The kappa statistic using the three categories was 0.64 for scoring solar elastosis in a test set of 19 sections by three dermatopathologists who individually scored 70%, 20% and 10% of the total slide collection. For the analyses in this report, solar elastosis was grouped as 2 categories, present (mild, moderate, severe elastosis) versus absent.
Phenotypic variables were assessed by items in a self-administered questionnaire for participant's natural hair color as a teenager, eye color, and skin color on the inside of the upper arm (16) , and instructions for a count of nevi (moles) on the back, which, for analysis, were categorized as 0-10 and more than 10. Questions in a telephone interview asked for propensity to burn on first exposure to sunlight in summer in 4 categories as 'no sunburn', 'mild burn then peel', 'painful burn then peel', 'severe burn with blistering' and ability to tan on repeated exposure to sunlight in 4 categories as 'go very brown and deeply tanned' to 'get no suntan or get freckled only'. Questions asked the number of each of painful and blistering sunburns at each decade of age in each of the warmer and cooler months and whether the melanoma site was usually burnt on these occasions; for analysis, these were dichotomized as any versus none. angle, ozone column, and surface elevation, as described by Lee-Taylor and Madronich (21) .
UV
The model used a discrete ordinates method (22) , and a pseudo-spherical correction (23) .
Corrections for variations in the Earth-Sun distance and for cloud cover (24) were applied.
Ozone column and cloud reflectivity data were obtained from the satellite-borne Total Ozone We estimated a cumulative site-specific UV dose for each of UVE, UVA and UVB as the total ambient UV for an assumed average 8 hours a day multiplied by the proportion of total sun exposure hours for which each participant reported exposure of the site. The seasonal values for warmer months and cooler months were combined for an annual dose and totaled over a lifetime from age 5. UVE, UVA and UVB were all highly correlated (R 2 > 0.99), although ambient UVB irradiance is more sensitive to the slant ozone column amount than is ambient UVA. Thus in this report, we present the analyses for UVE alone. The median and inter quartile range (IQR) for cumulative site-specific UVE in participants in each GEM center is presented in Figure 1 . Sitespecific beach and water UVE dose was calculated in a similar fashion to total dose, substituting beach and water hours for total outdoor hours.
Statistical Analysis. Age in these analyses was the patient's age at diagnosis of the melanoma for which the dermatopathologist scored solar elastosis in adjacent skin. GEM-wide quantiles were used in these analyses to categorize sun exposure variables into quarters of exposure for presentation in the Tables and into eighths for presentation in Figure 2 , using cut points based on the exposure distribution in all participants. We examined the association of demographic, phenotypic and sun exposure variables with solar elastosis and estimated odds ratios (ORs) and 95% confidence intervals (CI) for the presence of solar elastosis with reference to none, calculated in logistic regression models adjusted for age as a continuous variable, sex, We assessed the strength of the association between solar elastosis and total reported hours of sun exposure, total site-specific hours (when the body site was exposed), ambient UVE at residential locations, total site-specific UVE (that is, integrating reported sun exposure behavior and UVE), each in quartiles with the lowest quartile as the reference, and site-specific beach and water UVE in exposure tertiles with no exposure as the reference. Site-specific hours and UVE were also modeled as continuous variables, and we present the odds per 1000 hours and per megajoule per meter plotting each variable in turn against the log odds of solar elastosis (25) . The approach to assessing sun exposure effects was to model each sun exposure variable with adjustment for age, sex, center and to include as covariates the phenotypic characteristics back nevi, hair, eye and skin color, ability to tan and propensity to burn. Models for site-specific sun exposure also included a four-category variable for body site of the melanoma as head and neck, arms, legs, and trunk. To explore the extent to which age was an independent correlate of solar elastosis, we compared the estimates for age adjusted only for sex and center and when included in the multivariable model of sun exposure and phenotypic characteristics. In addition to examining the size of any change in odds for solar elastosis and its statistical significance, we used the Akaike information criterion (AIC) to compare models and select the best fitting model to explain the observed data, given the candidate set of models (28) .
We calculated the corrected AIC (AIC c ) values, which include a bias adjustment for the number of parameters relative to the sample size, and considered the best model as the one with the smallest AIC c .
Results
Of the 3,289 participants with incident primary melanomas in the GEM study, 2,746 Risk of solar elastosis increased substantially with age to OR, 11.91 at 70+ years, with reference to 11-40 years (Table 1 ) and the OR for each year of age was 1.05 (95% CI, 1.04-1.06). More men than women had solar elastosis (59.6% vs. 49.0%) although the OR for solar elastosis in men, relative to women, was close to 1.0 when adjusted for age and study center. The odds for solar elastosis by tertile of age were reasonably similar for men and women together and separately although the increase with age was steeper in women than men ( Table 2 ). When site-specific UVE dose was also included in the multivariable model, the effects of hair and eye color weakened and there was evidence of a stronger trend in the odds for solar elastosis as tanning ability decreased or sunburning increased ( Table 2 ). The effects of the pigmentary variables were substantially similar when examined in a multivariable model of all pigmentary variables (as in Table 2 ) and when each variable was examined separately adjusted only for age, sex and center (results not shown).
Having >10 nevi on the back, relative to <10, reduced the odds of solar elastosis (OR, 0.80; 95% CI 0.65-0.98; P value = 0.03) and was little changed when adjusted for pigmentary variables except the P value was 0.07 (data not shown). The addition of site-specific UVE dose caused the effect of back nevi to strengthen a little to OR, 0.77 (95% CI, 0.61-0.97) for >10 nevi (P = 0.03). In additional analyses, we found that the reduced odds for solar elastosis associated with the nevus propensity was mainly present for the trunk, arms and legs (OR, 0.75; 95% CI 0.59-0.96; P = 0.02) and was not at all evident for the head and neck (OR, 1.12; 95% CI 0.36-3.49; P = 0.84), but the P value for interaction was 0.61.
Age was strongly and independently associated with elastosis in a model including sitespecific UVE, phenotypic variables and back nevi. The addition of these variables, however, reduced the odds for age by 1% for each year of age from OR, 1.06 to OR, 1.05 (95% CI 1.04- Solar elastosis was associated most strongly with estimates of cumulative sun exposure to the body site. Site-specific sun exposure hours increased the odds for solar elastosis to an OR of 5.12 for the top exposure quartile (Q4; P value for trend < 0.001; Table 3 ) and the OR for the continuous measure was 1.05 (95% CI, 1.03-1.06; P < 0.001) for each 1000 site-specific hours.
Inclusion of ambient UVE in this measure to give site-specific UVE dose increased the OR to 5.20 for Q4 (Table 3 ) and the OR for the continuous measure was 1.11 (95% CI, 1.08-1.14; P < 0.001) per MJ/m 2 . Total outdoor hours without consideration of exposure of the body site or UVE increased the odds for solar elastosis to an OR of 2.13 for Q4 (P value for trend < 0.001) while cumulative ambient UVE, as a non-specific measure based only on places of residence, had no evident association with solar elastosis (OR, 1.29 for Q4; P for trend = 0.49) although the inclusion of center as a covariate to account for different pathology reviewers in different centers would have substantially limited between subject variation in UVE in this analysis. We also examined site-specific UV dose for hours spent in beach and water activities as a measure of recreational sun exposure. The odds for the highest exposure tertile, with reference to no beach and water activities, was OR, 2.37; 95% CI 1.70-3.30; P for trend <0.001. All sun exposure models were adjusted for age, sex, center and all phenotypic variables; site-specific measures were also adjusted for body site.
Site-specific UVE appears to be the best predictor of solar elastosis in these data. For exposure in quartiles (Table 3) In separate analyses by body site, the odds for solar elastosis were high for site-specific 
Discussion
We found that cumulative site-specific UVE dose had a strong positive dose-response relationship with histologic solar elastosis adjacent to melanomas. Additionally, site-specific UVE dose was the best of a number of sun exposure measurements in accounting for solar elastosis, judging by the AIC statistic. We also found that solar elastosis had a strong positive association with age even after adjusting for cumulative site-specific UVE dose and that elastosis occurred more frequently in skin on the sun-exposed head and neck and the arms than on the lesser exposed trunk and legs. Having more than 10 nevi on the back reduced the overall chance of solar elastosis. In addition to high cumulative sun exposure, our results indicate that older age and a tendency to fewer nevi were the personal characteristics that increased the chance of solar elastosis.
The strong positive association of histologic solar elastosis with cumulative sun exposure in GEM supports similar findings in previous studies that examined histologic solar elastosis in skin cancer patients (5, 14) or photoaging ratings in silicone skin casts in the general population (5) and GEM melanoma patients and 90% or more of New Hampshire BCC and SCC patients (14) . Australian residents too had high skin damage scores (3.9 and 4.9 for each hand on a scale of 6) (15). The finding in GEM that high levels of sun exposure increased the chance of solar elastosis more on the head and neck than at other body sites was in agreement with studies that directly measured sun exposure (5, 14) or examined tissue (5, 12, 29) at different body sites. Unlike the very strong and consistent association with cumulative sun exposure, site-specific lifetime recreational sun exposure increased the odds for solar elastosis but not strongly in our study and only for intermediate exposure levels in the New Hampshire study (14) or not significantly in Queensland patients (5).
Karagas et al. (14) were the first to report the strong association of solar elastosis with cumulative sun exposure to the site, but did not present results for non-specific measures and did not incorporate ambient UV, as we did. The strong associations we observed in GEM for sitespecific exposure can be ascribed to reducing exposure misclassification and giving weight to the environment by incorporating ambient UV and site-specific exposure hours into a single measure. We have shown that adding environmental UVE to self-reported sun exposure hours can improve site-specific sun exposure measurement. The results of our study support the use of solar elastosis as a biomarker of cumulative sun exposure in epidemiological studies that collect skin tissue.
The positive correlation of age with solar elastosis agrees with the greater prevalence at older ages in New Hampshire, especially in women (14) , and in Australia (5, 15, 30) . Both age and cumulative sun exposure were independently associated with solar elastosis in our study and potentially also in the US and Australian studies, which both mention that adjusting for age did not weaken the relationship with cumulative sun exposure. They do not, however, report estimates for age when adjusted for sun exposure (14, 15) . The strong association with age may be due to a contribution of intrinsic aging to solar elastosis or to the accumulation of UV exposure with age that is not fully addressed by adjusting for sun exposure in the epidemiological studies, or to other unmeasured variables. We expect that future studies, perhaps incorporating site-specific UVE measurements, will attempt to disentangle the contributions of aging and sun exposure in causing sun-related conditions such as solar elastosis or skin cancer.
Our observation that a high nevus count on the back in the GEM study reduced the odds of solar elastosis by 20% is consistent with the Queensland study in which there was some evidence that greater numbers of nevi may have reduced the odds for solar elastosis, based on patient numbers (5) , and the Australian general population study in which having any nevi reduced the odds of sun damage to 0.39 (95% CI, 0.23-0.66) (15) .
Sun exposure is known to be positively associated with both nevus count (31) and presence of solar elastosis. Thus we could reasonably expect the nevus propensity to be associated with a greater likelihood of solar elastosis. Instead, the available evidence indicates that solar elastosis was less likely in the presence of a higher nevus count (5) even after controlling for sun exposure and sun sensitivity (see Table 3 and (15)). Since nevi are genetically determined (32) (33) (34) , there may be a genetic component to the resistance to solar elastosis. In our study, the reduced odds ratio for solar elastosis associated with the nevus propensity was due mainly to solar elastosis on the trunk, arms and legs. We suggest that being less prone to solar Our results for phenotype are moderately supportive of the importance of a sun sensitive phenotype for solar elastosis (15) . Reduced tanning ability and a severe sunburn response to unprotected exposure were each associated with solar elastosis in our study and strengthened on adjustment for sun exposure, although not significantly so, but there was no strong and consistent effect of skin or hair color. Similarly, tanning and skin color (assessed by colorimeter) had no evident effect either way on solar elastosis in BCC and SCC patients (14) while the Queensland study did not report on pigmentary characteristics (5). There may not yet be sufficient evidence for the role of host phenotype in the development of skin damage. The lack of prominence for phenotype, especially fair skin, in association with solar elastosis in studies of normal skin in skin cancer patients may be a consequence of most patients having fair skin (88% had fair or very fair skin in GEM).
Sunburn is considered to be a measure of intermittent sun exposure. Unlike the strong relationship with cumulative site-specific UVE, sunburn had no evident association with solar elastosis in our study or the New Hampshire study (14) . A possible explanation is that people who burn readily may accumulate less time in the sun and thus are less likely to experience marked solar elastosis. Having sunburns or blistering sunburns, however, had a two-fold or more increased odds of sun damage after adjusting for cumulative whole body sun exposure, but not pigmentary characteristics, in the Australian general population study (15) . There is no ready explanation for this inconsistency. Possibilities include differences in the nature of skin damage 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Copyright © 2010 American Association for Cancer Research when measured by skin cast or histologic assessment, differences due to the body site examined since the back of the hand is known to be less susceptible to skin cancer, or the possibility of confounding with an underlying genetic component (37) that is more common in people with skin cancer than in the general population. Another possibility is that the high UV environment of the Australian population offered a greater opportunity to experience sunburn (87% reported any sunburn, 66% blistering sunburn) (15) than in GEM (64% any sunburn, 45% blistering sunburn) or New Hampshire (57% painful sunburn) (14) . We interpret the lack of an effect of sunburn on solar elastosis in the skin cancer studies as further support for the contribution of cumulative sun exposure, and not intermittent sun exposure, to solar elastosis.
Our finding that the risk of solar elastosis was higher for site-specific UVE in people who reported no sunscreen use on the body site than in users is the first report of an apparently protective effect of sunscreens against this type of sun damage. It is, however, consistent with a strong inverse dose-response relationship between amount of sunscreen used regularly and development of new solar keratoses and remission of existing ones (38) , and with prevention of SCC, but not BCC, by recent use of sunscreens (39) .
Among the advantages of this report are the standardized histopathology review by expert pathologists of all melanoma slides including the scoring of solar elastosis, the study's large international population base, accounting for potential confounding by phenotype, and the detailed sun exposure measurements integrating behavior with objective ambient UV measurements and restricting exposure to times when the site was exposed to the sun. All participants had melanoma and were unlikely to be aware of whether they had solar elastosis or not, thus minimizing the potential for recall bias. The measures incorporating behavior, however, may have inaccuracies due to error in self-reported exposure hours over a lifetime. Our site-specific UVE dose may have other sources of error because it included only exposure hours between 9am and 5pm (up to 15% of ambient UVE falls outside of 9am-5pm, see Madronich, 1993 (40) ) and could make no allowance for variation in ambient UVE irradiance between 9am and 5pm.
Variables used in the modeling were not predictive of missing data for solar elastosis, except for center location, which was mainly due to the different percentages of participants with diagnostic slides available for review. Although all study participants had melanoma and thus our results might be considered not to apply more widely, the consistency of our results with the strong association of cumulative UVR dose and skin damage reported in the general population (15) supports their wider applicability.
We found that solar elastosis was strongly associated with cumulative lifetime sitespecific UV dose. This relationship is biologically plausible. Our study was the first to demonstrate the extent of the improvement gained in evaluating the relationship between sun exposure and solar elastosis by using site-specific measurements and, additionally, the stronger effect estimates that resulted from accounting for ambient UV. We conclude that solar elastosis could be a useful biomarker of cumulative sun exposure in epidemiological studies that collect skin biopsies. The strong relationship of solar elastosis with age could indicate the possibility of an explanation other than a simple accumulation of sun exposure over time. Finally, the inverse, independent relationship with number of nevi may suggest that people with a genetic predisposition to nevi may be less prone to sun damage. Future studies would usefully include possible genetic markers of relevance, including any that may be related to solar elastosis. Mean, median and interquartile range experienced at the body site by participants in GEM centers (NSW, New South Wales; TAS, Tasmania, Australia; S CAL, Southern California; N CAR, North Carolina; NJ, New Jersey, BR COL, British Columbia, Canada; ONT, Ontario, Canada; TOR, Torino, Italy). Site-specific UVE dose was calculated as total ambient UVE (estimated by NCAR for each participant's place of residence at each decade of age) for an assumed average 8 hours a day multiplied by the proportion of total sun exposure hours that the site was exposed for each participant. This sun exposure measure takes into account both site-specific sun exposure behavior and ambient UV irradiance. Figure 2 . ORs for solar elastosis on all body sites in 2,304 GEM participants: cumulative sun exposure measures in eight ordered categories containing equal numbers of participants in models adjusted for age, sex, center, pigmentary characteristics and nevi; site-specific exposure also adjusted for body site (head and neck, trunk, arms, legs). Total hours and site-specific hours of sun exposure were reported by participants; site-specific UVE was calculated as total ambient UVE for an assumed average 8 hours a day multiplied by the proportion of total sun exposure hours that the site was exposed for each participant.
